Close Menu
    What's Hot

    UK Bulk Annuity Insurers’ Exposure to Private Credit Set To Remain Manageable

    July 20, 2026

    UK Bulk Annuity Insurers’ Exposure to Private Credit Set To Remain Manageable

    July 20, 2026
    Milliman

    Competitive US Pension Risk Transfer Cost Decreased During June

    July 20, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      Pacific Life Re Appoints Florence Durousseau as Head of Capital Solutions, Europe

      June 15, 2026

      Third Block Reinsurance Deal With Tokio Marine & Nichido Life for Pacific Life Re

      June 10, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      UK Bulk Annuity Insurers’ Exposure to Private Credit Set To Remain Manageable

      July 20, 2026

      UK Bulk Annuity Insurers’ Exposure to Private Credit Set To Remain Manageable

      July 20, 2026
      Milliman

      Competitive US Pension Risk Transfer Cost Decreased During June

      July 20, 2026

      Rolls-Royce Completes Bulk Purchase Annuity Buy-Out Transition With PIC

      July 16, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026

      UK Equity Release Market Waits on Fourth Quarter for Potentially Market-Altering Change

      June 24, 2026

      Q&A: James Westerlind, Partner, ArentFox Schiff

      June 24, 2026

      UK Bulk Annuity Insurers’ Exposure to Private Credit Set To Remain Manageable

      July 20, 2026

      UK Bulk Annuity Insurers’ Exposure to Private Credit Set To Remain Manageable

      July 20, 2026
      Milliman

      Competitive US Pension Risk Transfer Cost Decreased During June

      July 20, 2026

      Rolls-Royce Completes Bulk Purchase Annuity Buy-Out Transition With PIC

      July 16, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

    Life Insurance March 25, 2026By Greg Winterton
    Share
    Twitter LinkedIn Email

    The European Insurance and Occupational Pensions Authority (EIOPA) has turned its head towards the almost zeitgeist topic of ‘private equity’ ownership of life insurers. On 3rd February, it published ‘Consultation on supervisory statement on the authorisation and ongoing supervision of (re-)insurance undertakings related to private equity’, a new consultation paper that is “seeking to address the risks and ensure high-quality and convergent supervision of (re-)insurance undertakings related to private equity firms, considering their specific nature and risks.” 

    While not being a Supervisory Statement as yet, this Consultation Paper could be seen as a new ‘manual of expectations’ for national regulators. The document covers four main areas: the PE firm’s acquisition strategy and business model; governance and conflicts of interest; prudential aspects; and leverage. 

    According to Luca Tres, Head of Strategic Risk and Capital Life Solutions, EMEA at Guy Carpenter, the paper connects to prior efforts.  

    “There is ‘fil rouge’ here. This is an EIOPA supervisory trajectory that started with their work on run-off in 2022 and 2023. There the authority had already pointed to the growing financial investors’ role in the industry and the potential implications. The current document continues that work,” he said. 

    “Anything EIOPA touches on this document is not new. It is already the common supervisory practice in a number of jurisdictions. The real focus here seems to be convergence across supervisory practices.” 

    The use of private credit and other alternative assets by PE-backed insurers gets a mention in the consultation. This has been a bone of contention in the US in the past few years with regards to the pension risk transfer market as class action lawsuits claiming that some plan sponsors do not select the ‘safest annuity available’ (as mandated by ERISA) for their de-risking partner. 

    The UK regulator the Prudential Regulation Authority has also weighed in on the topic, making a few comments relating to its concerns about the prevalence of the use of funded reinsurance to reinsure bulk purchase annuity liabilities. 

    Therefore, it is perhaps of little surprise that EIOPA also has a view but according to Tres, the debate isn’t about the assets themselves. 

     “Private assets are not inherently good or bad, but they can be riskier when governance and investment capabilities are not sophisticated enough,” he said. 

    The requirement for adequate expertise in asset management is not necessarily a new one per se – Article 132 of the existing Solvency II regulations is the ‘prudent person principle’. And indeed, other notable takeaways from EIOPA’s consultation appear to be reminders and/or variations on an existing requirement. 

    Among these is EIOPA’s suggestion that an acquiring PE firm submit a three-year business plan to the national regulators so that they can “assess how the future business model of the undertaking will allow it to comply with the prudential requirements laid down in Article 59(1)(d) of the Solvency II Directive, especially if undertakings’ revenues and/or solvency position is expected to be optimized.” 

    EIOPA’s paper also says that if the information provided is not considered sufficient, national regulators might want to think about requiring the minutes of the PE investment committee or the Board that has decided on the acquisition. 

    This might sound intrusive on the surface, but again, Solvency II’s Own Risk and Solvency Assessment (ORSA) already requires forward-looking, multi-year business/solvency projections. 

    “EIOPA is not building a PE-specific regulatory regime here. What it is doing is aligning insurance supervision with how sophisticated M&A and financial supervision is already conducted in some jurisdictions and, as discussed, standardising it across member states,” said Tres.  

    “It is worth reminding that the regulatory convergence topic across member states and their supervisory authorities is surely a key priority for EIOPA. This document is part of that trajectory,” he added. 

    The consultation paper covers other topics, of course. Governance and conflicts of interest being another significant one (where EIOPA wants to ensure that asset management decisions remain independent, for example) and comments on leverage, capital enhancements and financing (EIOPA requires stress testing of debt repayment, scrutiny of liens/pledges, tailored reporting, and ORSA scenarios to protect solvency and liquidity). 

    Responses to EIOPA’s consultation are due at the end of April and it would not be a surprise if responses are plentiful. But for Tres, if you dispassionately look at the paper, it’s not anti-private equity. 

    “This is not a compatibility issue. EIOPA isn’t saying that private equity funds and other asset managers can’t be players in this market. EIOPA’s guidance reads more like a supervisory reminder: where ownership structures are complex or incentives could favour value extraction over resilience, supervisors should increase scrutiny. It’s essentially a nudge — perhaps amplified because the issue is topical,” he said. 

    EIOPA had not replied to the offer to provide a comment prior to publication. 

    2026 - March Alternative Credit Volume 2 Issue 4 – April 2026
    Share. Twitter LinkedIn Email

    Related Posts

    UK Equity Release Market Waits on Fourth Quarter for Potentially Market-Altering Change

    June 24, 2026By Greg Winterton

    Japanese Life Insurance Industry Offering the Capital Markets Plenty of Opportunities

    May 28, 2026By Greg Winterton

    Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

    April 22, 2026By Greg Winterton

    Editor’s Letter – Volume 2, Issue 4, April 2026

    April 9, 2026By Chris Wells
    Latest Issue

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.